Validating a Hospital Medicines Formulary Survey in the Western Pacific Region-A global hospital pharmacy initiative based on the Basel Statements

Research in Social and Administrative Pharmacy

Volumn 8, Issue 4, 2012, Pages 298-308

  Penm, Jonathan ^a,b   Chaar, Betty ^b   Moles, Rebekah ^b  

^a SYDNEY EYE HOSPITAL   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Basel Statements; Formulary; Hospital pharmacy; Pharmacy and Therapeutics Committee; Validation; Western Pacific Region

Indexed keywords

ARTICLE; ASIA; AUSTRALIA; CLINICAL COMPETENCE; CLINICAL TRIAL; EVIDENCE BASED MEDICINE; HEALTH CARE SURVEY; HEALTH PERSONNEL ATTITUDE; HOSPITAL PHARMACY; HUMAN; LANGUAGE; MULTICENTER STUDY; PACIFIC ISLANDS; PERCEPTION; PHARMACIST; PRACTICE GUIDELINE; PRINCIPAL COMPONENT ANALYSIS; PROFESSIONAL PRACTICE; PSYCHOLOGICAL ASPECT; PUBLICATION; QUESTIONNAIRE; STANDARD; VALIDATION STUDY;

ASIA; ATTITUDE OF HEALTH PERSONNEL; AUSTRALIA; CLINICAL COMPETENCE; EVIDENCE-BASED MEDICINE; FORMULARIES, HOSPITAL; GUIDELINE ADHERENCE; HEALTH CARE SURVEYS; HUMANS; LANGUAGE; PACIFIC ISLANDS; PERCEPTION; PHARMACISTS; PHARMACY SERVICE, HOSPITAL; PRACTICE GUIDELINES AS TOPIC; PRINCIPAL COMPONENT ANALYSIS; PROFESSIONAL PRACTICE; QUESTIONNAIRES;

EID: 84864291169     PISSN: 15517411     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.sapharm.2011.07.003     Document Type: Article

References (56)

1. The Basel Statements on the future of hospital pharmacy. Am J Health Syst Pharm 2009, 66(suppl 3):S61-S66.
2. Cousins D. Current status of the monitoring of medication practice. Am J Health Syst Pharm 2009, 66(suppl 3):S49-S56.
3. Nissen L. Current status of pharmacist influences on prescribing of medicines. Am J Health Syst Pharm 2009, 66(suppl 3):S29-S34.
4. Oishi R. Current status of preparation and distribution of medicines. Am J Health Syst Pharm 2009, 66(suppl 3):S35-S42.
5. Ombaka E. Current status of medicines procurement. Am J Health Syst Pharm 2009, 66(suppl 3):S20-S28.
6. Shane R. Current status of administration of medicines. Am J Health Syst Pharm 2009, 66(suppl 3):S42-S48.
7. Wuliji T. Current status of human resources and training in hospital pharmacy. Am J Health Syst Pharm 2009, 66(suppl 3):S56-S60.
8. Doloresco F., Vermeulen L.C. Global survey of hospital pharmacy practice. Am J Health Syst Pharm 2009, 66(suppl 3):S13-S19.
9. Gray A.L. Conference conclusions. Am J Health Syst Pharm 2009, 66(suppl 3):S75-S76.
10. Penm J., Chaar B., Moles R. Developing a validated survey to assess the Basel Statements: the Western Pacific Region's response. Int Pharm J 2010, 26:34-38.
11. World Health Organization Western Pacific Country Health Information Profiles: 2009 Revision 2009, WHO Press, Geneva, Switzerland.
12. World Health Organization District Health Facilities: Guidelines for Development & Operations 1998, WHO Press, Geneva, Switzerland.
13. Glossary of terms. Am J Health Syst Pharm 2009, 66(suppl 3):S67-S70.
14. Thürmann P.A., Harder S., Steioff A. Structure and activities of hospital drug committees in Germany. Eur J Clin Pharmacol 1997, 52:429-435.
15. Tyler L.S., Cole S.W., May J.R., et al. ASHP guidelines on the pharmacy and therapeutics committee and the formulary system. Am J Health Syst Pharm 2008, 65:1272-1283.
16. Ansani N.T., Ciliberto N.C., Freedy T. Hospital policies regarding herbal medicines. Am J Health Syst Pharm 2003, 60:367-370.
17. Beal F.C. Herbals and homeopathic remedies as formulary items?. Am J Health Syst Pharm 1998, 55:1266-1267.
18. Brubaker M.L. Setting up the herbal formulary system for an alternative medicine clinic. Am J Health Syst Pharm 1998, 55:435-436.
19. Feely J., Chan R., Cocoman L. Impact of a hospital formulary on prescribing habits and drug costs. Ir Med J 1987, 80:286-287.
20. Laing R. How to Develop a National Formulary Based on the WHO Model Formulary: A Practical Guide 2004, WHO Press, Geneva, Switzerland.
21. Sloan F.A., Gordon G.S., Cocks D.L. Hospital drug formularies and use of hospital services. Med Care 1993, 31:851-867.
22. Lucarelli C.D. Formulary management strategies for type 3 serotonin receptor antagonists. Am J Health Syst Pharm 2003, 60(suppl 1):S4-S11.
23. Singh M., Seftel A.D. The impact of formulary replacement of sildenafil by vardenafil at a local VA hospital. Int J Impot Res 2008, 20:188-191.
24. Longyhore D.S., Stockton C.M., Thomas M.R. Lipid profile changes associated with changing available formulary statins: removing higher potency agents. Am J Manag Care 2009, 15:409-414.
25. Grace K.A., Swiecki J., Hyatt R., et al. Implementation of a therapeutic-interchange clinic for HMG-CoA reductase inhibitors. Am J Health Syst Pharm 2002, 59:1077-1082.
26. Regal R.E., DePestel D.D., VandenBussche H.L. The effect of an antimicrobial restriction program on Pseudomonas aeruginosa resistance to beta-lactams in a large teaching hospital. Pharmacotherapy 2003, 23:618-624.
27. White A.C., Atmar R.L., Wilson J., Cate T.R., Stager C.E., Greenberg S.B. Effects of requiring prior authorization for selected antimicrobials: expenditures, susceptibilities, and clinical outcomes. Clin Infect Dis 1997, 25:230-239.
28. Guglielmo B.J., Dudas V., Maewal I., et al. Impact of a series of interventions in vancomycin prescribing on use and prevalence of vancomycin-resistant enterococci. Jt Comm J Qual Patient Saf 2005, 31:469-475.
29. Landman D., Chockalingam M., Quale J.M. Reduction in the incidence of methicillin-resistant Staphylococcus aureus and ceftazidime-resistant Klebsiella pneumoniae following changes in a hospital antibiotic formulary. Clin Infect Dis 1999, 28:1062-1066.
30. Goldstein E.J.C., Citron D.M., Peraino V., Elgourt T., Meibohm A.R., Lu S. Introduction of ertapenem into a hospital formulary: effect on antimicrobial usage and improved in vitro susceptibility of Pseudomonas aeruginosa. Antimicrob Agents Chemother 2009, 53:5122-5126.
31. Baker J.A., Lant A.F., Sutters C.A. Seventeen years' experience of a voluntarily based drug rationalisation programme in hospital. BMJ 1988, 297:465-469.
32. Rahal J.J., Urban C., Horn D., et al. Class restriction of cephalosporin use to control total cephalosporin resistance in nosocomial Klebsiella. JAMA 1998, 280:1233-1237.
33. Feely J., Chan R., Cocoman L., Mulpeter K., O'Connor P. Hospital formularies: need for continuous intervention. BMJ 1990, 300:28-30.
34. Winston L.G., Charlebois E.D., Pang S., Bangsberg D.R., Perdreau-Remington F., Chambers H.F. Impact of a formulary switch from ticarcillin-clavulanate to piperacillin-tazobactam on colonization with vancomycin-resistant enterococci. Am J Infect Control 2004, 32:462-469.
35. The truth about hospital formularies: survey shows many myths still exist 15 years later. Pa Nurse 2005, 60:30-33.
36. Rucker T.D., Schiff G. Drug formularies: myths-in-formation. Med Care 1990, 28:928-942.
37. Grissinger M. The truth about hospital formularies, part 2: survey shows many myths still exist years later. P T 2008, 33:504-510.
38. Stolar M.H. ASHP national survey of hospital pharmaceutical services-1987. Am J Hosp Pharm 1988, 45:801-818.
39. Pedersen C.A., Schneider P.J., Scheckelhoff D.J. ASHP national survey of pharmacy practice in hospital settings: dispensing and administration-2008. Am J Health Syst Pharm 2009, 66:926-946.
40. Pedersen C.A., Schneider P.J., Scheckelhoff D.J. ASHP national survey of pharmacy practice in hospital settings: monitoring and patient education-2009. Am J Health Syst Pharm 2010, 67:542-558.
41. Pedersen C.A., Schneider P.J., Scheckelhoff D.J. ASHP national survey of pharmacy practice in hospital settings: prescribing and transcribing-2010. Am J Health Syst Pharm 2011, 68:669-688.
42. World Health Organization National Policy on Traditional Medicine and Regulation of Herbal Medicines: Report of a WHO Global Survey 2005, WHO Press, Geneva, Switzerland.
43. Beaton D.E., Bombardier C., Guillemin F., Ferraz M.B. Guidelines for the process of cross-cultural adaptation of self-report measures. Spine 2000, 25:3186-3191.
44. Leplège A., Verdier A. The adaptation of health status measures: methodological aspects of the translation procedure. The International Assessment of Health-related Quality of Life: Theory, Translation, Measurement and Analysis 1995, 93-101. Rapid Communications, Oxford, UK. S.A. Shumaker, R. Berzon (Eds.).
45. Kimberlin C.L., Winterstein A.G. Validity and reliability of measurement instruments used in research. Am J Health Syst Pharm 2008, 65:2276-2284.
46. Cook C., Heath F., Thompson R.L. A meta-analysis of response rates in web- or internet-based surveys. Educ Psychol Meas 2000, 60:821-836.
47. Carmines E.G., Zeller R.A. Quantitative Applications in the Social Sciences: Reliability and Validity Assessment 1979, Sage Publications, Inc., Thousand Oaks, CA.
48. Pett M.A., Lackery N.R., Sullivan J.J. Making Sense of Factor Analysis: The Use of Factor Analysis for Instrument Development in Health Care Research 2003, Sage Publications, Inc., Thousand Oaks, CA.
49. Bowling A. Research Methods in Health: Investigating Health and Health Services 2009, Open University Press, Maidenhead, UK. 3rd ed.
50. Hair J.F., Black W.C., Babin B.J., Anderson R.E. Multivariate Data Analysis 2009, Prentice Hall, Upper Saddle River, NJ. 7th ed.
51. Kaiser H.F. A second generation Little Jiffy. Psychometrika 1970, 35:401-415.
52. Kaiser H.F. An index of factorial simplicity. Psychometrika 1974, 39:31-36.
53. Bartlett M.S. A note on the multiplying factors for various chi square approximations. J R Stat Soc 1954, 16(Series B):296-298.
54. Catell R.B. The scree test for number of factors. Multivariate Behav Res 1966, 1:245-276.
55. Thurstone L.L. Multiple-Factor Analysis 1947, University of Chicago Press, Chicago, IL.
56. DeVon H.A., Block M.E., Moyle-Wright P., et al. A psychometric toolbox for testing validity and reliability. J Nurs Scholarsh 2007, 39:155-164.